Shruthi Hemanna

Shruthi Hemanna

Auto-generated profile, based on publicly available information

Shruthi Hemanna

Medical Faculty Mannheim 1 European Center for Angioscience (ECAS) Heidelberg University, Heidelberg, Germany

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2024 in Science Translational Medicine
Verified
Journal Article
Closed access
FTFelix A Trogisch
Felix A Trogisch
AAAya Abouissa
Aya Abouissa
MKMerve Keles
Merve Keles
ABAnne Birke
Anne Birke
MFManuela Fuhrmann
Manuela Fuhrmann
JHJörg Heineke
Jörg Heineke
Fibrosis is a hallmark of chronic disease. Although fibroblasts are involved, it is unclear to what extent endothelial cells also might contribute. We detected increased expression of the transcription factor Sox9 in endothelial cells in several different mouse fibrosis models. These models included systolic heart failure induced by pressure overload, diastolic heart failure induced by high-fat diet and nitric oxide synthase inhibition, pulmonary fibrosis induced by bleomycin treatment, and liver fibrosis due to a choline-deficient diet. We also observed up-regulation of endothelial SOX9 in cardiac tissue from patients with heart failure. To test whether SOX9 induction was sufficient to cause disease, we generated mice with endothelial cell–specific overexpression of Sox9 , which promoted fibrosis in multiple organs and resulted in signs of heart failure. Endothelial Sox9 deletion prevented fibrosis and organ dysfunction in the two mouse models of heart failure as well as in the lung and liver fibrosis mouse models. Bulk and single-cell RNA sequencing of mouse endothelial cells across multiple vascular beds revealed that SOX9 induced extracellular matrix, growth factor, and inflammatory gene expression, leading to matrix deposition by endothelial cells. Moreover, mouse endothelial cells activated neighboring fibroblasts that then migrated and deposited matrix in response to SOX9, a process partly mediated by the secreted growth factor CCN2, a direct SOX9 target; endothelial cell–specific Sox9 deletion reversed these changes. These findings suggest a role for endothelial SOX9 as a fibrosis-promoting factor in different mouse organs during disease and imply that endothelial cells are an important regulator of fibrosis.

23 October 2026
Verified
Other
Open access
EREmma Reynaud
Emma Reynaud
SBSonya Belherazem
Sonya Belherazem
SHShruthi Hemanna
Shruthi Hemanna
SHSarah Hofmann
Sarah Hofmann
AAAlperen Acari
Alperen Acari
LDLothar Dieterich
Lothar Dieterich
Supplementary Table S2 from Lymph Node Lymphatic PD-L1 Regulates Tumor-Infiltrating T Cells in Immune Checkpoint–Sensitive Melanoma

23 October 2026
Verified
Other
Open access
EREmma Reynaud
Emma Reynaud
SBSonya Belherazem
Sonya Belherazem
SHShruthi Hemanna
Shruthi Hemanna
SHSarah Hofmann
Sarah Hofmann
AAAlperen Acari
Alperen Acari
LDLothar Dieterich
Lothar Dieterich
List of antibodies used for flow cytometry

23 October 2026
Verified
Other
Open access
EREmma Reynaud
Emma Reynaud
SBSonya Belherazem
Sonya Belherazem
SHShruthi Hemanna
Shruthi Hemanna
SHSarah Hofmann
Sarah Hofmann
AAAlperen Acari
Alperen Acari
LDLothar Dieterich
Lothar Dieterich
PD-L1 expression by LN LECs in human melanoma–draining LNs. A, Representative microscopy images of immunofluorescence staining for CD73 (red), PROX1 (green), PD-L1 (pink), podoplanin (D2-40, light blue), PRAME (yellow), and nuclei (blue) in a human melanoma–draining LN. Zoomed-in views show a representative area of the SCS and the cortical region. B, Quantification of PD-L1 mean fluorescence intensity in the total LN area and SCS area by CD73- and podoplanin-defined subsets of PROX1+ LECs (>2,000/patient) after intensity normalization to the double-negative (DN) subset. N = 3 patients. **, P < 0.01; one-way ANOVA with a Šídák post test. PODO, podoplanin. C, Kaplan–Meier curves of CD274 gene expression correlating with overall survival in human melanoma data (SKCM-The Cancer Genome Atlas dataset, filtered for LN as site of resection/biopsy). The median value of gene expression was used as cutoff. Statistical analysis was conducted using the log-rank test. D, Immunofluorescence images of a representative tdLN from a patient with melanoma stained for claudin-5 and PD-L1. E, Zoomed-in views from an SCS area of melanoma-draining LNs for representative NR and R patients. F, Quantification of PD-L1 mean fluorescence intensity in SCS area and inner LN area by claudin-5+ vascular structures after normalization to a low PD-L1 level background. N = 4–6 patients/group. Student t test.

23 October 2026
Verified
Other
Open access
PDF file
EREmma Reynaud
Emma Reynaud
SBSonya Belherazem
Sonya Belherazem
SHShruthi Hemanna
Shruthi Hemanna
SHSarah Hofmann
Sarah Hofmann
AAAlperen Acari
Alperen Acari
LDLothar Dieterich
Lothar Dieterich
Flow cytometry analysis of B cells in tdLNs and the TME

23 October 2026
Verified
Other
Open access
PDF file
EREmma Reynaud
Emma Reynaud
SBSonya Belherazem
Sonya Belherazem
SHShruthi Hemanna
Shruthi Hemanna
SHSarah Hofmann
Sarah Hofmann
AAAlperen Acari
Alperen Acari
LDLothar Dieterich
Lothar Dieterich
Flow cytometry analysis of myeloid innate immune cells in tdLNs and the TME